Paweł Petryszyn
Wroclaw Medical University(PL)AstraZeneca (Poland)(PL)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Health Systems, Economic Evaluations, Quality of Life, Helicobacter pylori-related gastroenterology studies, Gastroesophageal reflux and treatments
Most-Cited Works
- → Gastric Cancer: Where Are We Heading?(2020)203 cited
- → Enhanced formation of advanced oxidation protein products in IBD(2008)67 cited
- → Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis(2019)55 cited
- → A panel of stomach‐specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area(2020)48 cited
- → Stool patterns and symptoms of disordered anorectal function in patients with inflammatory bowel diseases(2018)48 cited
- → Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients—A Systematic Review and Meta-Analysis(2022)41 cited
- → Costs in inflammatory bowel diseases(2016)29 cited
- → Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries(2022)22 cited
- → Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis(2019)18 cited
- → Infliximab, adalimumab, golimumab, vedolizumab and tofacitinib in moderate to severe ulcerative colitis: comparative cost-effectiveness study in Poland(2020)17 cited